Home
The future of clinical development depends on better decisions
Quantive Intelligence Decision Sciences brings biometrics, analytics, strategy and submission expertise into a single platform created to help life sciences organizations navigate clinical complexity with greater clarity, confidence and precision.
What Is Quantive Intelligence
A new platform, built on a proven foundation
Quantive Intelligence brings together three established biometrics service providers: TechData, LLX, and R Square, into a single Decision Sciences Platform.
TechData’s biometrics and FSP expertise and LLX’s submission capabilities, coupled with R Square’s innovative solutions, now operate as one integrated platform, connecting the analytical and regulatory work required to move clinical programs forward.
A Partner
Quantive Intelligence is a partner built to support decisions across the full clinical development lifecycle
Why It Matters
Clinical development has entered a more demanding era
Clinical programs are generating more data, increasingly in real time, while facing higher regulatory expectations and moving through more complex development pathways.
At the same time, many sponsors still rely on fragmented models that separate analytics, biometrics, and submission planning across multiple partners.
That separation creates handoffs where clarity is lost, context is delayed, and decisions become harder to defend. As the industry moves toward real-time and continuous trials, that fragmentation becomes costlier still the pace of data now outstrips the models built to interpret it.
Built to support every decision in a trial
Solutions
From study design to submission, QI operates across the analytical and regulatory continuum
We help sponsors make decisions that are structured, evidence-based, and ready for regulatory scrutiny.
Biostatistics & Programming
Statistical strategy, analysis, and programming that turns trial data into defensible evidence.
Data Management
Clean, structured, decision-ready data captured and managed for the questions that matter.
Regulatory & Submission
CDISC implementation and submission strategy built to hold up under regulatory scrutiny.
DMC / DSMB Services
Independent oversight and safety monitoring that keeps trials moving with confidence.
Consulting & Strategy
Senior-level guidance from study design through approval strategy, across therapeutic areas.
Staffing & FSP
Expert teams embedded in your network, operating as a seamless extension of your own.
Who it’s built for
From first in human to top-20 pharma
Quantive Intelligence is built to scale to the decision, not the company size. Emerging biotechs get senior expertise from day one. Established sponsors get a partner equipped to operate across an entire portfolio. The platform meets you where your program is – and grows with it.
01
Emerging Biotech
Senior-level decision support from the earliest stages of clinical development.
02
Mid-Size Sponsors
Integrated, bespoke solutions providing support across growing programs.
03
Large / Top-20 Pharma
Platform-scale capability for complex, multi-program portfolios.
Leadership
The people behind the platform
Quantive Intelligence is led by a team of seasoned industry professionals alongside the founders and senior experts who together built the platform.
